Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼ö¾Æ¼¼Æ÷Á¾: Ä¡·á°á°ú¿Í ¿¹ÈÄÀÎÀÚ¿¡ ´ëÇÑ ¿¬±¸ Medulloblastoma: Outcome and Prognostic Factors

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1993³â 22±Ç 2È£ p.188 ~ 198
¼Ò¼Ó »ó¼¼Á¤º¸
À±¼öÇÑ À̱Լº/¹Ú¿ë±¸/ÃÖÁß¾ð/Á¤»ó¼·/À̱Ôâ

Abstract


43 patients with medulloblastoma of the posterior fossa were treated at the Department of Neurosurgery Yonsei Universtiy College of Medicine from 1981 to 1991. Major treatment were surgery, irradiation, chemotherapy or combination. Mean follow-up
was 30
months (range, 1 to 120 months). Kaplan-Meier actuarial survival for all patients 59% at 3 years. Disease free survival was 53% at 3 years. Radiation and treatment period (before 1986 vs after 1986) affected outcome significantly. But other
prognosic
factors such as age, extent of surgical resection and chemotherapy did not affect outcome statistically. Follow-up more than 3 years showed very low recurrence rate.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS